CAT-1004 (Catabasis) Clinical Trial Webinar [May 2015] On May 13, 2015, Dr. Joanne Donovan, Chief Medical Officer at Catabasis Pharmaceuticals, presented information about MoveDMD: an upcoming Phase 1/2 clinical trial with CAT-1004 in boys with Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 10 years ago You may also like 1:05:45 Early Pulmonary Care Webinar (September 2014) 10 years ago Care Webinars,Webinars 41:57 Translarna™ (ataluren) update (June 2014) 11 years ago Research & Clinical Trial Webinars,Webinars 1:09:01 Prosensa Update on Drisapersen (March 2014) 11 years ago Research & Clinical Trial Webinars,Webinars 1:03:22 ACT DMD Update with PTC (February 2014) 11 years ago Research & Clinical Trial Webinars,Webinars 1:05:32 Clinical Trials in Duchenne: A Behind the Scenes Look (December 2013) 11 years ago Research & Clinical Trial Webinars,Webinars 1:15:13 Update on Natural History Data Study with Dr. Craig McDonald (November 2013) 11 years ago Research & Clinical Trial Webinars,Webinars 56:44 Prosensa Update on Duchenne Program (August 2013) 11 years ago Research & Clinical Trial Webinars,Webinars 51:35 MD STARnet (March 2013) 12 years ago Research & Clinical Trial Webinars,Webinars «1…2122232425»Page 23 of 25
by: Parent Project Muscular Dystrophy
